首页 >
法规速递
-
Page: Guidance on good manufacturing practice and good distribution practice: Questions and answers-2025/1/31
2025-02-05查看详情 > -
Document: List of centrally authorised products with safety-related changes to the product information-2025/1/31
2025-02-05查看详情 > -
Page: Website outages and upgrades-2025/1/31
2025-02-05查看详情 > -
Page: Clinical trials in human medicines-2025/1/31
2025-02-05查看详情 > -
Page: Clinical Trials Information System (CTIS): online training modules-2025/1/31
2025-02-05查看详情 > -
Page: Clinical Trials Information System-2025/1/31
2025-02-05查看详情 > -
Document: Draft reflection paper on the use of information in European Union herbal monographs and assessment reports for borderline issues-2025/1/31
2025-02-05查看详情 > -
Document: Member states contact points for translations review-2025/1/31
2025-02-05查看详情 > -
Page: Product-specific bioequivalence guidance-2025/1/31
2025-02-05查看详情 > -
Document: Paclitaxel (nanoparticle albumin-bound) powder for suspension for infusion, 5mg/ml-2025/1/31
2025-02-05查看详情 >
